This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

WHO fracture risk assessment tool (FRAX)

Authoring team

WHO fracture risk assessment tool (FRAX)

After studying population-based cohorts from Europe, North America, Asia and Australia, the WHO has developed a tool (FRAX) which is able to evaluate fracture risk of a patient (1).

  • the tool is based on individual patient models that integrate the risks associated with clinical risk factors as well as bone mineral density (BMD) at the femoral neck
  • it gives the 10 year probability of a fracture - hip fracture and of a major osteoporotic fracture (clinical spine, forearm, hip or shoulder fracture)

Clinical risk factors used in the WHO FRAX tool include:

  • current age
  • gender
  • a prior osteoporotic fracture - including a morphometric vertebral fracture, prior clinical vertebral fracture or a hip fracture is an especially strong risk factor
  • femoral neck BMD
  • low body mass index
  • oral glucocorticoids for more than 3 months at a dose of prednisolone of 5mg daily or more (or equivalent doses of other glucocorticoids)
  • current smoking
  • parental history of hip fracture
  • alcohol intake (3 or more units a day)
  • rheumatoid arthritis
  • secondary osteoporosis e.g. - type I diabetes, untreated long-standing hyperthyroidism, hypogonadism or premature menopause (<45 years), chronic malnutrition, or malabsorption etc.

The tool is available on WHO Fracture Risk Assessment Tool site

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.